Epredia
Epredia is a precision cancer diagnostics company providing histology instrumentation, consumables, digital pathology scanners, immunohistochemistry products, and cytology equipment to clinical pathology laboratories, academic research institutions, and pharmaceutical companies worldwide.
- Company typePrivate
- Founded2019
- HeadquartersKalamazoo, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Epredia does
Epredia is a precision cancer diagnostics company that provides a comprehensive portfolio of histology instrumentation, consumables, digital pathology solutions, immunohistochemistry (IHC) products, and cytology equipment to clinical pathology laboratories, research institutions, and pharmaceutical companies globally. Established in July 2019 through PHC Holdings Corporation's acquisition of Thermo Fisher Scientific's Anatomical Pathology business, the company builds on heritage brands including Shandon, Microm, Menzel Gläser, and Richard-Allan Scientific, with operational roots dating to 1937. The company reports products are used 48 times every second and over one billion customer touchpoints per year across its installed base.
The product portfolio spans the full anatomical pathology workflow. Capital equipment includes tissue processors, embedders, microtomes, cryostats, stainers, coverslippers, and slide/cassette printers. The SlideMate Laser (600 dpi laser printing, enabling 50 characters per barcode vs. 23 with conventional technology) and SlideMate Thermal Slide Printer are flagship products for sample traceability. Digital pathology is anchored by the FDA 510(k) cleared E1000 Dx whole-slide imaging scanner, capable of processing up to 1,500 tissue samples daily, complemented by the QuantCenter image analysis software platform and ClearVue coverslipper. AI image analysis is integrated through distribution partnerships with Mindpeak, Aiforia, and Paige, delivering pixel-level cancer diagnostics for breast, lung, and gastrointestinal pathology. Recurring revenue is driven by histology consumables including reagents, paraffin, microscope slides, blades, cassettes, biopsy bags, H&E and special stains, and archiving supplies.
Epredia employs a hybrid go-to-market combining direct enterprise field sales with regional customer care centers in the US (Portsmouth, NH; Kalamazoo, MI), UK (Runcorn), Germany (Dreieich), Italy (Milan), and Benelux, complemented by channel partners for AI solutions and a factory store for excess inventory. Manufacturing is distributed across the US, France (Lyon, via acquired MMFrance and Laurypath), and Italy (San Benedetto del Tronto), with engineering/R&D presence in the UK (Shandon Diagnostics) and Hungary (Pathology Innovation Incubator joint venture with 3DHISTECH). The company is a wholly-owned subsidiary of PHC Holdings Corporation (TSE: 6523), a publicly traded Japanese healthcare conglomerate that received TSE listing approval in October 2021.
Epredia firmographics
Firmographics- Name
- Epredia
- Legal name
- Epredia
- Website
- https://epredia.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Epredia is a precision cancer diagnostics company providing histology instrumentation, consumables, digital pathology scanners, immunohistochemistry products, and cytology equipment to clinical pathology laboratories, academic research institutions, and pharmaceutical companies worldwide.
- Ownership category
- akta.pro rank
Epredia industry classification
Industry- Product category
- Anatomical Pathology Diagnostics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE)
- akta.pro secondary industries
- Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Anatomic Pathology & Histopathology (Trial Support) (HLAGAEAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Epredia is headquartered
LocationHeadquarters
- HQ city
- Kalamazoo
- HQ country
- United States
- HQ region
- North America
Offices12 records
Markets served
Epredia business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Histology Instrumentation Sales: Sale of capital equipment including tissue processors, embedders, microtomes, cryostats, stainers, coverslippers, and slide/cassette printers to pathology laboratories. One-time capital purchase model with recurring service and support contracts.
- Histology Consumables: Recurring revenue from consumable products including reagents, paraffin, microscope slides, blades, cassettes, biopsy bags, coverglass, mounting media, frozen media, H&E and special stains, prefills, and archiving supplies.
- Digital Pathology Solutions: Whole-slide imaging scanners (Dx and Rx), tissue microarrayers, image analysis software, image management software, and digital pathology accessories. Capital equipment sales with software licensing and support.
- Immunohistochemistry Products: IHC instruments, primary antibodies, detection kits, and ancillaries for diagnostic and research use on flexible open platforms.
- Cytology Products: Cytospin instruments, Cytofunnels, Cytoslides, and reagents and stains for cytology applications.
- Distribution Partnership Revenue: Revenue from distribution partnerships including global distribution rights for Aiforia, Paige, and Mindpeak AI pathology solutions, expanding the product portfolio without direct R&D investment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Direct sales with regional customer care and support |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels9 records
Epredia product offering
Product offeringCore offering
Epredia manufactures and distributes precision cancer diagnostics products for anatomical pathology laboratories worldwide. Its core offerings span histology instrumentation (tissue processors, embedders, microtomes, cryostats, stainers, slide/cassette printers), histology consumables (reagents, paraffin, microscope slides, blades, cassettes, stains), digital pathology whole-slide imaging scanners and image management/analysis software, immunohistochemistry (IHC) instruments and reagents, and cytology products.
Differentiator
Problem solved
Functional benefit
Brands
- SlideMate: Slide printing instruments including SlideMate Laser and SlideMate Thermal Slide Printer for pathology laboratories
- E1000 Dx
- Revos
- NOVA
- VEGA
- QuantCenter
- ClearVue
- Cytospin
Products and services
- E1000 Dx Digital Pathology Solution High-speed, automated whole-slide imaging scanner for clinical cancer diagnostics, producing high-resolution digital images of up to 1,500 tissue samples daily to reduce turnaround times and improve pathologist productivity. FDA 510(k) cleared.
- SlideMate Thermal Slide Printer Thermal transfer printing system for pathology laboratories designed to produce permanent labels on microscope slides, with enclosed slide hoppers to protect samples from dust contamination. Engineered for integration into histology, cytology, and other pathology workflows.
- SlideMate Laser Printer 600 dpi high-resolution laser printing technology for microscope slides, enabling up to 50 characters in a barcode per slide compared to 23 characters in conventional thermal transfer and inkjet technologies, with LIS connectivity for workflow integration.
- NOVA and VEGA Laser Cassette Printers 600 dpi laser cassette printers enabling up to 100 characters per cassette compared to 50 characters in older thermal transfer and inkjet technologies, improving sample tracking throughout the diagnostic workflow.
- Histology Instrumentation Portfolio Capital equipment including tissue processors, embedders, microtomes, cryostats, stainers, coverslippers, and slide/cassette printers for pathology laboratories.
- Histology Consumables Recurring consumable products including reagents, paraffin, microscope slides, blades, cassettes, biopsy bags, coverglass, mounting media, frozen media, H&E and special stains, prefills, and archiving supplies for histology laboratories.
- Immunohistochemistry (IHC) Products IHC instruments, primary antibodies, detection kits, and ancillaries for diagnostic and research use on flexible open platforms.
- Cytology Products Cytospin instruments, Cytofunnels, Cytoslides, and reagents and stains for cytology applications.
- Digital Pathology Whole Slide Imaging and Image Management Software Whole-slide imaging scanners (Dx and Rx), tissue microarrayers, image analysis software, image management software, and digital pathology accessories sold as digital pathology solutions with software licensing and support.
- 3DHISTECH P1000 WSI Scanner Commercial partnership for digital slide-scanning technology, distributing the 3DHISTECH P1000 WSI Scanner as part of Epredia's digital pathology portfolio.
Quantifiable outcome
- E1000 Dx processes up to 1,500 tissue samples daily
- +4 more outcomes
Companies that use Epredia
Customer profileSegments4 records
Ideal customer profiles4 records
Epredia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature6 records
Epredia partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- MindpeakcoreEU distribution agreement for Mindpeak's AI-powered image recognition software. Provides pixel-level analysis of digital tissue images for breast cancer, lung cancer, and gastrointestinal pathology diagnostics. Designed to reduce variability and improve workflow efficiency for pathology laboratories. Integration planned into Epredia's E1000 Dx digital pathology workflow for seamless image interpretation and data exchange.
- 3DHISTECHcoreJoint venture for Pathology Innovation Incubator in Budapest, Hungary. Commercial partners in digital slide-scanning technology. Both companies financially support and contribute knowledge transfer and technology exchange to develop solutions for faster and more accurate cancer diagnosis. Opened March 2023 with support from Hungarian Ministry of Foreign Affairs and Trade.
- RegenMed Hub Innovation AcceleratorminorPHC Group and Epredia joined the RegeneratOR Innovation Accelerator in Winston-Salem, North Carolina. Focus on regenerative medicine with local office established. Epredia serves as global distribution partner for Aiforia's preclinical and clinical pathology tools within this ecosystem.
- AiforiacoreGlobal distribution partnership for Aiforia's portfolio of workflow-improving solutions using deep learning AI for image analysis in pathology. Epredia has segment exclusivity for distribution in Japan, Germany, UK, Italy, Spain, Sweden, Norway, Denmark, Iceland, France, and USA. Also led Aiforia's Series B funding round (€12.6M initial tranche, potentially €25.2M with second tranche).
- PaigecoreGlobal distribution agreement for Paige's portfolio of AI-based diagnostic software solutions for pathology. Epredia has exclusive distribution rights in Japan. Marketing began Q2 2021 in US and major European countries alongside existing Epredia products.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Epredia competitors and assessment
Company assessmentDirect peers
- Hologic: Hologic's cytology and diagnostics business, including the ThinPrep system, competes directly with Epredia's Cytospin cytology product line and broader cytology reagents and stains portfolio.
- Danaher (Leica Biosystems): Leica Biosystems is a leading manufacturer of histology instruments, consumables and digital pathology solutions, directly competing with Epredia across the anatomical pathology workflow including tissue processors, stainers, microtomes and whole-slide imaging scanners.
- Sakura Finetek: Sakura Finetek manufactures tissue processors, embedding systems, microtomes and histology consumables, directly competing with Epredia's histology instrumentation and consumables offerings across hospital and independent labs.
- Hamamatsu Photonics: Hamamatsu is a leading manufacturer of whole-slide imaging scanners and digital pathology systems, directly competing with Epredia's E1000 Dx Digital Pathology Solution and broader digital pathology portfolio.
- 3DHISTECH: 3DHISTECH manufactures digital slide scanners and pathology workflow solutions, both as a commercial partner of Epredia (P1000 WSI Scanner distribution, Budapest JV) and a direct competitor in the digital pathology market.
- Roche (Ventana Medical Systems): Roche's Ventana division is a major competitor in anatomic pathology, offering automated staining systems, IHC instruments, primary antibodies and digital pathology solutions that directly overlap with Epredia's histology, IHC and digital pathology portfolios.
Broad incumbents
- Agilent Technologies: Agilent's pathology and IHC portfolio, including Dako reagents and primary antibodies, competes with Epredia's immunohistochemistry products and overlaps in the broader life science tools and diagnostics market.
- Philips (Digital Pathology): Philips' IntelliSite Digital Pathology Solution competes with Epredia's E1000 Dx in clinical whole-slide imaging, with Philips leveraging a broader healthcare IT portfolio and larger installed base across integrated hospital systems.
Emerging players
- Paige.AI: Paige develops AI-based diagnostic software for pathology with which Epredia has a global distribution agreement; Paige is both a partner and emerging competitive threat as it builds direct relationships with health systems for AI-native pathology.
- Aiforia: Aiforia provides deep-learning AI image analysis tools for clinical and preclinical pathology, partnered with Epredia for distribution globally. Aiforia is both a channel partner and an emerging competitor as it pursues CE-IVD-marked clinical tools in breast and lung cancer diagnostics.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Epredia social profiles
Digital presenceEpredia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Epredia leadership team
Management profileNumber of profiles
Profiles11 records
Epredia subsidiaries and ownership
Company hierarchySubsidiaries7 records
Epredia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Epredia M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Epredia
What does Epredia do?
Epredia manufactures and distributes precision cancer diagnostics products for anatomical pathology laboratories worldwide. Its core offerings span histology instrumentation (tissue processors, embedders, microtomes, cryostats, stainers, slide/cassette printers), histology consumables (reagents, paraffin, microscope slides, blades, cassettes, stains), digital pathology whole-slide imaging scanners and image management/analysis software, immunohistochemistry (IHC) instruments and reagents, and cytology products.
Is Epredia a public or private company?
Epredia is a private company. It is classified as corporate owned and is currently operating.
When was Epredia founded?
Epredia was founded in 2019. It employs 1,001 to 5,000 people.
Where is Epredia based?
Epredia is headquartered in Kalamazoo, United States, in the North America region.
How does Epredia make money?
Six revenue lines are on record. Histology Instrumentation Sales are the primary driver. The others are histology Consumables, digital Pathology Solutions, immunohistochemistry Products, cytology Products and distribution Partnership Revenue.
Who are Epredia's main competitors?
Direct peers on record are Hologic, Danaher (Leica Biosystems), Sakura Finetek, Hamamatsu Photonics, 3DHISTECH and Roche (Ventana Medical Systems). Broad incumbents are Agilent Technologies and Philips (Digital Pathology). Emerging players are Paige.AI and Aiforia.
Does Epredia have an API?
No public API is recorded for Epredia.
What industry is Epredia in?
Epredia's product category is Anatomical Pathology Diagnostics. Its primary akta.pro industry code is HLAHAAAE, Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics), with a secondary code of HLAHANAG, Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs). Its NAICS code is 339112 and its SIC code is 3841.